Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
B-SAFE: AV7909 vs BioThrax for Anthrax PEP in Elderly
NCT03518125Phase 2Completed
- Sponsor
- Biomedical Advanced Research and Development Authority
- Start
- May 2018
- Primary completion
- Jan 2019
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 2 trial of NuThrax in anthrax, sponsored by Biomedical Advanced Research and Development Authority. Started May 2018; status: completed.
02
Drugs
NuThrax
03
Conditions
anthrax
Beyond the preview
Go deeper on NCT03518125.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03518125.